Pharmacogenomics
Pharmacogenomics is the study of the role of genetics in drug response. It deals with the effect of genetic variation on drug response in patients by associating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Pharmacogenetics focuses on single drug-gene interactions. It helps in Improve drug safety, and reduce ADRs,Tailor treatments to meet patients' unique genetic pre-disposition, identifying optimal dosing.
- Genome sequencing
- Clinical Pharmacogenomics
- Genomics for optimized medical prescription
- More accurate methods of determining appropriate drug dosages
- Advanced screening for disease
Related Conference of Pharmacogenomics
Pharmacogenomics Conference Speakers
Recommended Sessions
- Case Reports
- Cancer Metabolomics
- Computational Methodologies
- Edibilomics
- Enzyme Nanotechnology
- Epigenomics and Epigenetics
- Lipidomics
- Mass Spectrometry based Metabolomics
- Metabolomics
- Metabolomics in Precision Medicine
- Microbial Metabolism
- Molecular Medicine and Diagnostics
- Next-generation sequencing
- Pharmacogenomics
- Proteomics
- Recent Advancements in Metabolomics
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Imaging and Super-Resolution Techniques - Structural Biology 2026 (Spain)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomolecular Dynamics and Allostery - Structural Biology 2026 (Spain)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Structural Biology and Artificial Intelligence - Structural Biology 2026 (Spain)
- Cryo-Electron Microscopy (Cryo-EM) - Structural Biology 2026 (Spain)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Integrative and Hybrid Structural Biology - Structural Biology 2026 (Spain)
- Membrane Protein Structure and Dynamics - Structural Biology 2026 (Spain)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Nuclear Magnetic Resonance (NMR) Spectroscopy - Structural Biology 2026 (Spain)
- Protein Engineering and Synthetic Biology - Structural Biology 2026 (Spain)
- Protein Structure and Function - Structural Biology 2026 (Spain)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Structural Basis of Genetic and Metabolic Disorders - Structural Biology 2026 (Spain)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Biology in Drug Discovery - Structural Biology 2026 (Spain)
- Structural Genomics and Proteomics - Structural Biology 2026 (Spain)
- Structural Immunology - Structural Biology 2026 (Spain)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Virus Structure and Host Interactions - Structural Biology 2026 (Spain)
- X-ray Crystallography and Diffraction Methods - Structural Biology 2026 (Spain)

